Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.33 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.33 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | KDM4B | O94953 | 1/20 | 0.30 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4903081 | 0.73 | CRHR1 (0.30) | SMN1; SMN2 | |
| SCHEMBL15921403 | 0.72 | L3MBTL1 (0.36) | ALDH1A1HTTSMN1; SMN2NPSR1KDM4E | |
| SCHEMBL15920991 | 0.72 | L3MBTL1 (0.38) | POLBL3MBTL1 | |
| Hydrochloric Acid SCHEMBL6444703 | 0.71 | ALDH1A1 (0.33) | TAS1R3TAS1R1TAS1R2ALDH1A1POLB | |
| SCHEMBL24445746 | 0.70 | KDM4E (0.31) | KDM4E | |
| SCHEMBL24445753 | 0.69 | — | — | |
| SCHEMBL13706025 | 0.68 | CYP3A4 (0.43) | ALDH1A1MAPTSMN1; SMN2KDRKDM4E | |
| SCHEMBL301559 | 0.68 | TAS1R3 (0.40) | TAS1R3TAS1R1TAS1R2ALDH1A1NPSR1 | |
| SCHEMBL13589306 | 0.65 | KDM4E (0.33) | ALDH1A1SMN1; SMN2TP53DRD4KDR | |
| SCHEMBL5423379 | 0.65 | L3MBTL1 (0.37) | ALDH1A1SMN1; SMN2TP53DRD4KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2427468-B2 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PLC (GB) | 2025-06-04 | — | — | EP | claimed |
| US-11939333-B2 | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same | INFINITY PHARMACEUTICALS, INC. (US) | 2024-03-26 | — | — | US | claimed |
| CN-117144368-A | Preparation method of efficient low-phosphorus corrosion inhibitor | 广东天祺环保科技有限公司 | 2023-12-01 | — | — | CN | claimed |
| EP-4267591-A2 | ORGANOMETALLIC COMPOUNDS | Umicore AG & Co. KG (DE) | 2023-11-01 | — | — | EP | claimed |
| CN-116802187-A | Organometallic compounds | 优米科尔股份公司及两合公司 | 2023-09-22 | — | — | CN | claimed |
| WO-2022136049-A2 | ORGANOMETALLIC COMPOUNDS | UMICORE AG & CO. KG (DE) | 2022-06-30 | — | — | WO | claimed |
| CN-107226779-B | Process for selective palladium catalysis of substituted diolefins to telomers | 国际香料和香精公司 | 2021-08-20 | — | — | CN | claimed |
| EP-3222610-B1 | METHOD FOR SELECTIVE PALLADIUM-CATALYZED TELOMERIZATION OF SUBSTITUTED DIENES | INT FLAVORS & FRAGRANCES INC (US) | 2018-12-05 | — | — | EP | claimed |
| US-20170275235-A1 | METHOD FOR SELECTIVE PALLADIUM-CATALYZED TELOMERIZATION OF SUBSTITUTED DIENES | INT FLAVORS & FRAGRANCES INC (US) | 2017-09-28 | — | — | US | claimed |
| EP-3222610-A1 | METHOD FOR SELECTIVE PALLADIUM-CATALYZED TELOMERIZATION OF SUBSTITUTED DIENES | International Flavors & Fragrances Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| EP-2975019-A1 | RUTHENIUM CATALYZED HYDROAMINOMETHYLATION | Evonik Degussa GmbH (DE) | 2016-01-20 | — | — | EP | claimed |
| EP-2951143-A1 | METHOD FOR THE CARBONYLATION OF OLEFINS | Evonik Degussa GmbH (DE) | 2015-12-09 | — | — | EP | claimed |
| EP-2951188-A1 | PHOSPHORUS LIGANDS AND METHOD FOR THE SELECTIVE RUTHENIUM-CATALYZED HYDROAMINOMETHYLATION OF OLEFINS | Evonik Degussa GmbH (DE) | 2015-12-09 | — | — | EP | claimed |
| WO-2015063543-A1 | HYDRIDOPALLADIUM(II) HALIDES AS PREFORMED CATALYSTS FOR SUZUKI-MIYAURA CROSS-COUPLING REACTIONS | LATVIAN INSTITUTE OF ORGANIC SYNTHESIS (LV) | 2015-05-07 | — | — | WO | claimed |
| WO-2014118046-A1 | METHOD FOR THE CARBONYLATION OF OLEFINS | EVONIK INDUSTRIES AG (DE) | 2014-08-07 | — | — | WO | claimed |
| WO-2014118038-A1 | PHOSPHORUS LIGANDS AND METHOD FOR THE SELECTIVE RUTHENIUM-CATALYZED HYDROAMINOMETHYLATION OF OLEFINS | EVONIK INDUSTRIES AG (DE) | 2014-08-07 | — | — | WO | claimed |
| US-8772520-B2 | Preparation of a metal complex | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2014-07-08 | — | — | US | claimed |
| US-20120116109-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-05-10 | — | — | US | claimed |
| EP-2427468-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-03-14 | — | — | EP | claimed |
| WO-2010128316-A1 | PREPARATION OF A METAL COMPLEX | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2010-11-11 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275235-A1 | METHOD FOR SELECTIVE PALLADIUM-CATALYZED TELOMERIZATION OF SUBSTITUTED DIENES | TELO2, MCM5, TAF5 | TAS1R3 3418/4885TAS1R1 3898/4885TAS1R2 3340/4885 |
| US-11939333-B2 | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same | PIK3CA, PIK3C2A, PIK3CD | TAS1R3 3856/4885TAS1R1 3953/4885TAS1R2 4301/4885 |
| US-20120116109-A1 | PREPARATION OF A METAL COMPLEX | PDCD1LG2, CD274, PDCD2L | TAS1R3 2182/4885TAS1R1 2371/4885TAS1R2 1493/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.